News & Analysis on Clinical Trial Services & Contract Research And Development
Researchers have achieved the first ever gene therapy success for muscular dystrophy using a new systemic approach, which demonstrated that the scientific challenges that have cast doubt on gene therapy ever being feasible for children with muscular...
Packaging company Crown Holdings is planning to sell its plastic closures business for approximately $750 million to European private equity firm PAI partners.
US company Ampacet has developed molecular tracers that allow manufacturers to monitor flexible and rigid cosmetics plastic packaging - at any stage in the supply chain - to help resolve security, counterfeiting, quality, liability and other issues.
The importance of high-throughput screening and human microdosing during clinical trial processes has highlighted an emerging trend in drug R&D that uses smaller and smaller test volumes, helped by sophisticated automation technologies and reagents.
The news that the widow of a man who died after taking Vioxx was awarded $253.4 million has opened up the possibility of US lawsuits filed by patients worldwide, who were prescribed the drug that was linked to an increase in heart attack occurrence.
Sandoz, the generics subsidiary of Swiss pharmaceutical company Novartis, is rumoured to be planning an acquisition in India in a move that would give it back the top slot in the sector.